Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Leading Edge Materials' Investor Update and Significant Activities (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Dri Healthcare Trust
T.DHT.UN
Alternate Symbol(s):
DHTRF
Healthcare
Biotechnology
DRI Healthcare Trust is a Canada-based company engaged in global pharmaceutical royalty monetization. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It acquires more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. Its portfolio...
includes Empaveli/Syfovre, Eylea I, Eylea II, Ilaris, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Simponi, Spinraza, Stelara, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, Zytiga, sebetralstat, and others. Its therapeutic areas include hematology, ophthalmology, influenza, endocrinology, dermatology, oncology, neurology, immunology, lysosomal storage disorder, hereditary angioedema, and others. The Company is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Takeda; Galderma Laboratories; and others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:DHT.UN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(70)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Aug 08, 2024 5:52pm
RE:Scotia raises target to US$21
Hey HermannHaller. Thx for this. Scotia gets it. The expense fraud will be a nothingburger a quarter or two from now. Management will end up being stronger/deeper with the
...more
(7)
•••
sunshine7
X
Comment by
sunshine7
on Aug 08, 2024 10:57am
RE:Scotia raises target to US$21
Don't tell payday...
(23)
•••
HermannHaller
X
Post by
HermannHaller
on Aug 08, 2024 9:26am
Scotia raises target to US$21
https://x.com/TSXDivStock/status/1821516499216941314
(12)
•••
raybay_98
X
Comment by
raybay_98
on Aug 07, 2024 4:04pm
RE:RE:RE:Q2 results are out....
Fishing for suckers oh my, you best grab your ankles! jmho
(82)
•••
BlueJay2020
X
Comment by
BlueJay2020
on Aug 07, 2024 12:14pm
RE:RE:Q2 results are out....
Me likey too! Kicking myself I didn't add yesterday, but bought more this morning at $12.50 and will buy more today around that price if I can. $15,50-16 could be achievable by year-end IMO
...more
(70)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Aug 07, 2024 11:55am
RE:Q2 results are out....
Mr. Market likey! Massive air pocket over $13. Probably too far for today, but buckle up when we get there. Still a super buy at $12.50 IMHO.
(7)
•••
sunshine7
X
Post by
sunshine7
on Aug 06, 2024 7:49pm
Q2 results are out....
Adjusted Cash Earnings per Unit – Basic = USD 0.49
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 06, 2024 5:01pm
New Press Release - DRI Healthcare Trust Reports Second Quarter 2024 Results
– Highest Normalized Total Cash Receipts in a single quarter since IPO, excluding milestones –– Trust internal investigation substantially complete with no impact to cash royalty receipts – –New executive leadership in place and in-depth review of governance practices underway –TORONTO, Aug. 6...
read article.
(70)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Jul 26, 2024 5:52pm
RE:No Buyers?
I was a buyer
(12)
•••
raybay_98
X
Post by
raybay_98
on Jul 26, 2024 2:52pm
No Buyers?
Must be waiting for the next shoe to drop? jmho
(70)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Jul 26, 2024 9:16am
RE:CIBC
Thx for this. 35% discount to estimated NAV (which is simply PV of estimated cash flows on existing book of business) makes for an outstanding entry point -- limited downside and a free option on
...more
(12)
•••
raybay_98
X
Comment by
raybay_98
on Jul 25, 2024 12:09pm
RE:CIBC
DJ Dri Healthcare Trust Price Target Cut to C$14.00/Share From C$17.00 by Truist Securities
(6297)
•••
retiredcf
X
Post by
retiredcf
on Jul 25, 2024 9:19am
CIBC
Have an $18.50 target. GLTA EQUITY RESEARCH July 24, 2024 Earnings Update DRI HEALTHCARE TRUST Q2/24 Preview: Hard To Focus On Results Right Now Our Conclusion Performance
...more
(82)
•••
BlueJay2020
X
Comment by
BlueJay2020
on Jul 22, 2024 11:29pm
RE:RE:RE:RE:RE:RE:RE:Buyers and Sellers
Just like you forgot to turn up these last few days as the stock was green. I love green days for this stock - not only do I make money I don't have to read your drivel.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
ReGen III: Pioneering a Cleaner Lubricants Future with Patented Re-Refining
Have you held units of a TD mutual fund through a discount broker? Learn more.